Strategic partnerships Baylor Genetics has expanded its client base through multi-year contracts with large healthcare systems, including a national VA contract for pharmacogenomic and germline testing, indicating strong potential for enterprise-level partnerships and managed services opportunities.

Expanded capabilities Recent enhancements to Whole Genome Sequencing adding optical genome mapping and long-read sequencing position Baylor Genetics to offer advanced diagnostic options, suggesting upsell potential to institutions seeking cutting-edge genomic analysis and comprehensive panels.

Pediatric and neurology focus Active engagement in pediatric neurology events and data presentation at specialty conferences signals ongoing demand in neonatal, pediatric, and neurologic genetics, presenting a clear path for targeted outreach to children’s hospitals and neurology clinics.

Security and governance Participation in patient-centered laboratory utilization guidance and strong emphasis on rapid, counselor-supported diagnostics highlight a value proposition for healthcare systems prioritizing patient outcomes, payer efficiency, and compliant, high-quality genomic services.

Scale and reach Serving clients in all 50 states with a diverse testing menu across pregnancy, neonatal, oncology, and family planning indicates broad market coverage and opportunities to cross-sell across departments in large health networks and integrated delivery systems.